Concepedia

Jean‐Michel Guillon

JG

Statistics

Publications

10

Citations

351

H-Index

10

Active since

1992

Affiliations

Sanofi (France)(Current)

Health and Environmental Sciences Institute

United States Food and Drug Administration

Eli Lilly (United States)

Novartis (United States)

Jean‐Michel Guillon is an author at Sanofi (France) specializing in medicine, pharmacology, and cardiology.

Publications per year

1992–2021

10

Publications

10

Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study

Daniel Millard, Qianyu Dang, Hong Shi et al. · Toxicological Sciences · 2018 · 130 citations · Full text

, , +16

The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium

Brian D. Guth, Alan Y. Chiang, Jennifer Doyle et al. · Journal of Pharmacological and Toxicological Methods · 2015 · 56 citations · Full text

, , +17

Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in epstein‐barr‐virus‐positive nasopharyngeal carcinoma cells

Pierre Busson, Qin Zhang, Jean‐Michel Guillon et al. · International Journal of Cancer · 1992 · 40 citations

, , +13

The isolated rabbit heart and Purkinje fibers as models for identifying proarrhythmic liability

Céline Renauleaud, Véronique Ballet, Michel Doubovetzky et al. · Journal of Pharmacological and Toxicological Methods · 2010 · 22 citations

, , +16

Reminiscing about Jan Evangelista Purkinje: a pioneer of modern experimental physiology

Icilio Cavero, Jean‐Michel Guillon, Henry H. Holzgrefe · AJP Advances in Physiology Education · 2017 · 22 citations · Full text

, , +15

1–5 of 10